| Year |
Citation |
Score |
| 2020 |
Lew G, Chen Y, Lu X, Rheingold SR, Whitlock JA, Devidas M, Hastings CA, Winick NJ, Carroll WL, Wood BL, Borowitz MJ, Pulsipher MA, Hunger SP. Outcomes after late bone marrow and very early central nervous system relapse of childhood B-Acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433. Haematologica. PMID 32001530 DOI: 10.3324/Haematol.2019.237230 |
0.34 |
|
| 2019 |
Horton TM, Whitlock JA, Lu X, O'Brien MM, Borowitz MJ, Devidas M, Raetz EA, Brown PA, Carroll WL, Hunger SP. Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group. British Journal of Haematology. PMID 30957229 DOI: 10.1111/Bjh.15919 |
0.324 |
|
| 2017 |
George TJ, Dang LH, Daily KC, Starr JS, Parekh HD, Ivey AM, Delitto D, Allegra CJ, Hughes SJ, Lu X, McEwan MA, Cioffi JL, Trevino JG. 5-fluorouracil, oxaliplatin and dasatinib (FOLFOX-D) for previously untreated metastatic pancreatic adenocarcinoma. Journal of Clinical Oncology. 35: TPS517-TPS517. DOI: 10.1200/Jco.2017.35.4_Suppl.Tps517 |
0.311 |
|
| 2017 |
Zheng D, Lu X, Ross WL, Angiolillo AL, Schore R, Balsamo LM, Devidas M, Whitley MK, Kadan-Lottick NS. Longitudinal analysis of quality of life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children’s Oncology Group (COG) AALL0932. Journal of Clinical Oncology. 35: 10522-10522. DOI: 10.1200/Jco.2017.35.15_Suppl.10522 |
0.311 |
|
| 2016 |
Yan M, Wen Y, Yang L, Wu X, Lu X, Zhang B, Huang W, Li P. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial. Trials. 17: 259. PMID 27216240 DOI: 10.1186/s13063-016-1385-2 |
0.447 |
|
| 2016 |
Chan E, Duckworth LV, Alkhasawneh A, Toro TZ, Lu X, Ben-David K, Hughes SJ, Rossidis G, Zlotecki R, Lightsey J, Daily KC, Dang L, Allegra CJ, King B, George TJ. Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma. Journal of Gastrointestinal Oncology. 7: 173-80. PMID 27034783 DOI: 10.3978/J.Issn.2078-6891.2015.071 |
0.31 |
|
| 2016 |
Zhou JD, Dong YH, Zhang SH, Zhao YY, Guo XF, Lu XH, Wang CS. Preparation of high-coverage fluorinated decyltrichlorosilane self-assembled monolayers Wuli Huaxue Xuebao/ Acta Physico - Chimica Sinica. 32: 1221-1226. DOI: 10.3866/PKU.WHXB201602175 |
0.303 |
|
| 2016 |
Wang L, Lu X, Wang J, Yang S, Song X. Facile synthesis of Fe@Fe2O3 nanochains exhibiting high heating efficiency in magnetic hyperthermia Journal of Alloys and Compounds. 681: 50-56. DOI: 10.1016/j.jallcom.2016.04.141 |
0.337 |
|
| 2016 |
Liu R, Yang YW, Yan XS, Feng S, Lu XX, Zhu TH, Jiang L, Wang M. Measurement and calculation of U and Th reaction rates in uranium mock assemblies Annals of Nuclear Energy. 92: 391-396. DOI: 10.1016/j.anucene.2016.01.048 |
0.482 |
|
| 2016 |
Li Y, Zhao Y, Lu X, Zhu Y, Jiang L. Self-healing superhydrophobic polyvinylidene fluoride/Fe3O4@polypyrrole fiber with core–sheath structures for superior microwave absorption Nano Research. 1-12. DOI: 10.1007/s12274-016-1094-x |
0.482 |
|
| 2015 |
Hastings C, Gaynon PS, Nachman JB, Sather HN, Lu X, Devidas M, Seibel NL. Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology Group. British Journal of Haematology. 168: 533-46. PMID 25308804 DOI: 10.1111/Bjh.13160 |
0.325 |
|
| 2015 |
Rabin KR, Hitzler J, Rodriguez V, Schore R, Angiolillo A, Burke MJ, Salzer W, Maloney K, Lu X, Devidas M, Loh ML, Raetz E, Hunger SP. Treatment-Related Mortality (TRM) in Children with Down Syndrome (DS) and B-Lymphoblastic Leukemia (B-ALL): An Interim Report from the Children's Oncology Group Trials AALL0932 and AALL1131 Blood. 126: 2502-2502. DOI: 10.1182/Blood.V126.23.2502.2502 |
0.309 |
|
| 2014 |
George TJ, Ivey AM, Daily KC, Dang LH, Watson S, Granicz R, McEwan MA, Scian J, Lu X, Iqbal A, Tan S, Zendejas I, Allegra CJ. Planned interim analysis of phase II study of sorafenib and capecitabine (SorCape) in previously treated metastatic colorectal cancer (mCRC): NCT01471353. Journal of Clinical Oncology. 32: 548-548. DOI: 10.1200/Jco.2014.32.3_Suppl.548 |
0.308 |
|
| 2014 |
George TJ, Ivey AM, Daily KC, Dang LH, Watson S, Granicz R, Tormes K, Lu X, Liu C, Allegra CJ, Behrns K, Hughes SJ, Ogunwobi OO, Trevino JG. Src inhibition through a phase II study of 5-fluorouracil, oxaliplatin, plus dasatinib (FOLFOX-D) in first-line metastatic pancreatic adenocarcinoma. Journal of Clinical Oncology. 32: 319-319. DOI: 10.1200/Jco.2014.32.3_Suppl.319 |
0.312 |
|
| 2014 |
Lew G, Lu X, Yanofsky R, Rheingold SR, Whitlock J, Gulig SD, Devidas M, Pulsipher M, Hastings CA, Winick NJ, Carroll WL, Borowitz MJ, Hunger S. The significance of minimal residual disease (MRD) in relapsed childhood B-lymphoblastic leukemia (B-ALL): A report from Children’s Oncology Group (COG) protocol AALL0433. Journal of Clinical Oncology. 32: 10014-10014. DOI: 10.1200/Jco.2014.32.15_Suppl.10014 |
0.308 |
|
| 2014 |
Lew G, Lu X, Yanofsky R, Rheingold SR, Whitlock J, An Q, Devidas M, Hastings CA, Winick NJ, Carroll WL, Borowitz MJ, Hunger S, Pulsipher MA. Outcomes after Intermediate-Risk Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) and the Role of Allogeneic Stem Cell Transplantation (SCT): A Report from Children's Oncology Group (COG) AALL0433 Blood. 124: 684-684. DOI: 10.1182/Blood.V124.21.684.684 |
0.302 |
|
| 2014 |
Niewerth D, Kaspers GJL, Jansen G, Meerloo Jv, Zweegman S, Jenkins G, Whitlock JA, Hunger SP, Lu X, Cloos J, Horton TM. Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-169 |
0.301 |
|
| 2013 |
Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML, Billett A, Homans A, Sandler E, Buchanan G. Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9). Journal of Pediatric Hematology/Oncology. 35: 509-13. PMID 23887024 DOI: 10.1097/Mph.0B013E31829F3235 |
0.324 |
|
| 2013 |
Duckworth LV, Chan E, Alkhasawneh A, Zuluaga-Toro T, Lu X, Hughes SJ, George TJ. HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E15145 |
0.303 |
|
| 2011 |
Raetz EA, Cairo MS, Borowitz MJ, Lu X, Devidas M, Reid JM, Goldenberg DM, Wegener WA, Whitlock JA, Adamson PC, Hunger SP, Carroll WL. Reinduction Chemoimmunotherapy with Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) in Children, Adolescents and Young Adults: Results From Children's Oncology Group (COG) Study ADVL04P2 Blood. 118: 573-573. DOI: 10.1182/Blood.V118.21.573.573 |
0.311 |
|
| Show low-probability matches. |